The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABG ACQUISITION CORP I | CL A SHS | G00496102 | 3,228 | 329,400 | SH | SOLE | 329,400 | 0 | 0 | ||
AFFIMED N V | COM | N01045108 | 20,595 | 2,422,964 | SH | SOLE | 2,422,964 | 0 | 0 | ||
ALIGN TECHNOLOGY INC | COM | 016255101 | 72,575 | 118,780 | SH | SOLE | 118,780 | 0 | 0 | ||
AMERISOURCEBERGEN CORP | COM | 03073E105 | 30,264 | 264,340 | SH | SOLE | 264,340 | 0 | 0 | ||
AMGEN INC | COM | 031162100 | 38,581 | 158,280 | SH | SOLE | 158,280 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 13,281 | 1,238,881 | SH | SOLE | 1,238,881 | 0 | 0 | ||
ATAI LIFE SCIENCES NV | SHS | N0731H103 | 1,388 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 51,352 | 3,248,100 | SH | SOLE | 3,248,100 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 117,489 | 339,300 | SH | SOLE | 339,300 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 1,068 | 11,000 | SH | SOLE | 11,000 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 51,764 | 1,210,570 | SH | SOLE | 1,210,570 | 0 | 0 | ||
BRISTOL-MYERS SQUIBB CO | COM | 110122108 | 98,517 | 1,474,370 | SH | SOLE | 1,474,370 | 0 | 0 | ||
CM LIFE SCIENCES III INC | *W EXP 04/30/202 | 125841114 | 258 | 99,998 | SH | SOLE | 99,998 | 0 | 0 | ||
CM LIFE SCIENCES III INC | CLASS A COM | 125841106 | 5,160 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
CVS HEALTH CORP | COM | 126650100 | 105,746 | 1,267,330 | SH | SOLE | 1,267,330 | 0 | 0 | ||
CYTEIR THERAPEUTICS INC | COM | 23284P103 | 2,568 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 14,829 | 749,310 | SH | SOLE | 749,310 | 0 | 0 | ||
DANAHER CORPORATION | COM | 235851102 | 103,297 | 384,920 | SH | SOLE | 384,920 | 0 | 0 | ||
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 2,362 | 103,717 | SH | SOLE | 103,717 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 14,138 | 386,190 | SH | SOLE | 386,190 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 21,730 | 50,890 | SH | SOLE | 50,890 | 0 | 0 | ||
ELEVATION ONCOLOGY INC | COM | 28623U101 | 1,357 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ENCOMPASS HEALTH CORP | COM | 29261A100 | 82,346 | 1,055,316 | SH | SOLE | 1,055,316 | 0 | 0 | ||
ENVISTA HOLDINGS CORPORATION | COM | 29415F104 | 50,377 | 1,165,860 | SH | SOLE | 1,165,860 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | UNIT 10/23/2027 | G3141W114 | 2,389 | 234,180 | SH | SOLE | 234,180 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 2,830 | 41,080 | SH | SOLE | 41,080 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 5,433 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
HALOZYME THERAPEUTICS INC | COM | 40637H109 | 29,473 | 649,052 | SH | SOLE | 649,052 | 0 | 0 | ||
HCA HEALTHCARE INC | COM | 40412C101 | 35,086 | 169,710 | SH | SOLE | 169,710 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 115,650 | 1,235,048 | SH | SOLE | 1,235,048 | 0 | 0 | ||
HUMANA INC | COM | 444859102 | 105,823 | 239,030 | SH | SOLE | 239,030 | 0 | 0 | ||
IDEXX LABS INC | COM | 45168D104 | 18,883 | 29,900 | SH | SOLE | 29,900 | 0 | 0 | ||
IKENA ONCOLOGY INC | COM | 45175G108 | 5,301 | 377,551 | SH | SOLE | 377,551 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 22,463 | 267,000 | SH | Call | SOLE | 267,000 | 0 | 0 | |
IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 6,727 | 522,712 | SH | SOLE | 522,712 | 0 | 0 | ||
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 1,398 | 140,680 | SH | SOLE | 140,680 | 0 | 0 | ||
JOUNCE THERAPEUTICS INC | COM | 481116101 | 1,824 | 268,295 | SH | SOLE | 268,295 | 0 | 0 | ||
LIVANOVA PLC | SHS | G5509L101 | 10,514 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
LONGVIEW ACQUISITION CORP II | *W EXP 99/99/999 | 54319Q113 | 585 | 427,178 | SH | SOLE | 427,178 | 0 | 0 | ||
LONGVIEW ACQUISITION CORP II | COM CL A | 54319Q105 | 20,932 | 2,135,900 | SH | SOLE | 2,135,900 | 0 | 0 | ||
MARAVAI LIFESCIENCES HLDGS I | COM CL A | 56600D107 | 52,396 | 1,255,597 | SH | SOLE | 1,255,597 | 0 | 0 | ||
MCKESSON CORP | COM | 58155Q103 | 30,744 | 160,760 | SH | SOLE | 160,760 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/202 | G5960S124 | 83 | 82,663 | SH | SOLE | 82,663 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | CL A SHS | G5960S108 | 7,180 | 744,000 | SH | SOLE | 744,000 | 0 | 0 | ||
MEDTRONIC PLC | SHS | G5960L103 | 74,567 | 600,720 | SH | SOLE | 600,720 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 473 | 149,170 | SH | SOLE | 149,170 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 2,032 | 96,438 | SH | SOLE | 96,438 | 0 | 0 | ||
MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | 2,270 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 89,650 | 789,658 | SH | SOLE | 789,658 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 37,953 | 389,980 | SH | SOLE | 389,980 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 62,392 | 376,330 | SH | SOLE | 376,330 | 0 | 0 | ||
NOVAVAX INC | COM NEW | 670002401 | 4,989 | 23,500 | SH | Put | SOLE | 23,500 | 0 | 0 | |
OMEGA ALPHA SPAC | CL A | G6749V107 | 2,697 | 271,038 | SH | SOLE | 271,038 | 0 | 0 | ||
ORION ACQUISITION CORP | *W EXP 02/19/202 | 68626A116 | 131 | 137,305 | SH | SOLE | 137,305 | 0 | 0 | ||
ORION ACQUISITION CORP | COM CL A | 68626A108 | 5,290 | 547,598 | SH | SOLE | 547,598 | 0 | 0 | ||
PETCO HEALTH & WELLNESS CO I | COM | 71601V105 | 110,805 | 4,944,450 | SH | SOLE | 4,944,450 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 6,358 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
REGENERON PHARMACEUTICALS | COM | 75886F107 | 106,335 | 190,380 | SH | SOLE | 190,380 | 0 | 0 | ||
RESEARCH ALLIANCE CORP II | COM CL A | 760873109 | 13,433 | 1,324,800 | SH | SOLE | 1,324,800 | 0 | 0 | ||
SARISSA CAPITAL ACQUISITN CO | UNIT 10/23/2027 | G7823W128 | 2,687 | 262,150 | SH | SOLE | 262,150 | 0 | 0 | ||
STRYKER CORPORATION | COM | 863667101 | 70,956 | 273,190 | SH | SOLE | 273,190 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 30,071 | 1,751,342 | SH | SOLE | 1,751,342 | 0 | 0 | ||
TENET HEALTHCARE CORP | COM NEW | 88033G407 | 25,200 | 376,180 | SH | SOLE | 376,180 | 0 | 0 | ||
THERMO FISHER SCIENTIFIC INC | COM | 883556102 | 92,303 | 182,970 | SH | SOLE | 182,970 | 0 | 0 | ||
UNIVERSAL HLTH SVCS INC | CL B | 913903100 | 47,674 | 325,577 | SH | SOLE | 325,577 | 0 | 0 | ||
VEEVA SYS INC | CL A COM | 922475108 | 42,314 | 136,080 | SH | SOLE | 136,080 | 0 | 0 | ||
VENTAS INC | COM | 92276F100 | 27,958 | 489,640 | SH | SOLE | 489,640 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 23,784 | 117,960 | SH | SOLE | 117,960 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 37,705 | 187,000 | SH | Call | SOLE | 187,000 | 0 | 0 | |
WELLTOWER INC | COM | 95040Q104 | 36,114 | 434,590 | SH | SOLE | 434,590 | 0 | 0 | ||
ZIMMER BIOMET HOLDINGS INC | COM | 98956P102 | 122,920 | 764,330 | SH | SOLE | 764,330 | 0 | 0 | ||
ZOETIS INC | CL A | 98978V103 | 42,708 | 229,170 | SH | SOLE | 229,170 | 0 | 0 |